IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 192 filers reported holding IMMUNOGEN INC in Q2 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | -50.0% | 1,257 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $6,000 | 0.0% | 1,257 | +11.2% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -45.5% | 1,130 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $11,000 | -8.3% | 1,130 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | -14.3% | 1,130 | -49.3% | 0.00% | -20.0% |
| Q4 2017 | $14,000 | -58.8% | 2,230 | -49.0% | 0.01% | -61.5% |
| Q3 2017 | $34,000 | +9.7% | 4,370 | -0.5% | 0.01% | 0.0% |
| Q2 2017 | $31,000 | +72.2% | 4,391 | -3.1% | 0.01% | +62.5% |
| Q1 2017 | $18,000 | +80.0% | 4,530 | -3.6% | 0.01% | +60.0% |
| Q4 2016 | $10,000 | -16.7% | 4,700 | +4.1% | 0.01% | -16.7% |
| Q3 2016 | $12,000 | -20.0% | 4,513 | -2.1% | 0.01% | -14.3% |
| Q2 2016 | $15,000 | -61.5% | 4,612 | 0.0% | 0.01% | -63.2% |
| Q1 2016 | $39,000 | -32.8% | 4,612 | +7.2% | 0.02% | -26.9% |
| Q4 2015 | $58,000 | – | 4,304 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
| QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
| Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
| Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
| PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
| Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
| Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
| DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
| DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |